Galena Biopharma Fund Predictions

Buy GALE

*Your capital is at risk

$0.260

+0 (+0%)

At Close: Apr 17, 2018

Currently predicting for Mon, 8 Jun 2026

GALE Prediction Chart

GALE Predictions History

Latest community submissions for GALE.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Eugene @Eugene.128	Apr 29, 2016	$1.35 -95.11%	$1.38	V	97.80%	0
Eugene @Eugene.128	Apr 28, 2016	$1.37 -95.21%	$1.43	V	95.80%	0
Eugene @Eugene.128	Apr 27, 2016	$1.37 -95.07%	$1.39	V	98.60%	1
Eugene @Eugene.128	Apr 26, 2016	$1.34 -95.18%	$1.39	V	96.40%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GALE with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GALENA BIOPHARMA

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. The companys lead product candidate, NeuVax (nelipepimut-S), is in Phase III clinical trials for the prevention of recurrence in early- stage and node-positive breast cancer with low to intermediate human epidermal growth factor receptor (HER2) expression; Phase IIb clinical trials in combi...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by